Abstract:The incidence of diabetes has been increasing in recent decades which is affecting the population of both, developed and developing countries. Diabetes is associated with micro and macrovascular complications which predominantly result from hyperglycemia and disrupted metabolic pathways. Persistent hyperglycemia leads to increased reactive oxygen species (ROS) generation, formation of misfolded and abnormal proteins, and disruption of normal cellular functioning. The inability to maintain metabolic homeostasis under excessive energy and nutrient input, which induces insulin resistance, is a crucial feature during the transition from obesity to diabetes. According to various study reports, redox alterations, intracellular stress and chronic inflammation responses have all been linked to dysregulated energy metabolism and insulin resistance. Autophagy has been considered a cleansing mechanism to prevent these anomalies and restore cellular homeostasis. However, disrupted autophagy has been linked to the pathogenesis of metabolic disorders such as obesity and diabetes. Recent studies have reported that the regulation of autophagy has a beneficial role against these conditions. When there is plenty of food, nutrient-sensing pathways activate anabolism and storage, but the shortage of food activates homeostatic mechanisms like autophagy, which mobilises internal stockpiles. These nutrient-sensing pathways are well conserved in eukaryotes and are involved in the regulation of autophagy which includes SIRT1, mTOR and AMPK. The current review focuses on the role of SIRT1, mTOR and AMPK in regulating autophagy and suggests autophagy along with these nutrient-sensing pathways as potential therapeutic targets in reducing the progression of various diabetic complications.

The ubiquitin-proteasome system and autophagy: self-digestion for metabolic health

Autophagy and Its Link to Type II Diabetes Mellitus

Dysregulated autophagy: A key player in the pathophysiology of type 2 diabetes and its complications

Autophagy and Mitochondria in Obesity and Type 2 Diabetes

The role of autophagy in the treatment of type II diabetes and its complications: a review

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

The role of autophagy in insulin resistance and glucolipid metabolism and potential use of autophagy modulating natural products in the treatment of type 2 diabetes mellitus

Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes

Autophagy modulators in type 2 diabetes: A new perspective

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Autophagy-nutrient sensing pathways in diabetic complications

Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment

Ubiquitin Proteasome System Role in Diabetes-Induced Cardiomyopathy

Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management

Pancreatic β-Cells, Diabetes and Autophagy

Autophagic dysfunction of β cell dysfunction in type 2 diabetes, a double-edged sword

New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome

Role of autophagy in the progression from obesity to diabetes and in the control of energy balance

The Reciprocal Interaction Between Autophagic Dysfunction and ER Stress in Adipose Insulin Resistance.

Relationship between autophagy and T2DM and intervention effect of traditional Chinese medicine